<qa>  What is the oral, third-generation platinum analog that has been shown to increase prostatic specific- Satraplatin is an oral, third-generation platinum analog that has recently been shown to increase prostatic specific antigen PSA decline rates and progression-free survival in hormone-resistant prostate cancer. 